News from us and our partners

Tags

Topics

0 results

News
12 August, 2019
AgroSavfe raises €35 million in Series C financing
News
12 August, 2019
Sofinnova Partners Announces the Sale of Breath Therapeutics to Zambon
News
19 July, 2019
AgroSavfe appoints Patrice Sellès as new Chief Executive Officer and further strengthens leadership team
News
18 July, 2019
Labiotech.eu - The Business of Biotech: What to Do When the S*#t Hits the Fan - Antoine Papiernik
News
16 July, 2019
Comet Bio Completes Equity Financing and Opens U.S. Headquarters in Chicagoland Area
News
16 July, 2019
ABIVAX Completes €12 Million Capital Raise Entirely Subscribed by Sofinnova Partners at Market Price
News
11 July, 2019
AblaCare Announces Series A Financing of €10 Million by Sofinnova Partners for Innovative Infertility Treatment and Appoints Jodie Fam as CEO
News
10 July, 2019
DMC Biotechnologies, Inc. Announces First Close of $10.3M Series A Financing Led by Sofinnova Partners
News
19 June, 2019
Comet Therapeutics Raises $28.5 Million Series A Financing to Support Development of Treatments Built Around Its Novel CoEnzyme A Platform
News
16 May, 2019
Sofinnova Partners’ DNA Script Raises $38.5 Million in Series B Financing
News
14 May, 2019
CinCor Pharma In-Licenses Aldosterone Synthase Inhibitor, CIN-107, and Closes $50 Million Series A Financing
News
13 May, 2019
Sofinnova leads 28-7 Therapeutics' $15M Series A extension
News
22 April, 2019
HOOKIPA Pharma Announces Pricing of Initial Public Offering
News
10 April, 2019
NodThera Highlights Significant Progress with Advancement of Lead Development Candidate and Key Additions to Board
News
5 April, 2019
SafeHeal obtains CE-mark for Colovac, its novel endoluminal bypass sheath
News
14 March, 2019
AFYREN and the SPI industrial projects fund, operated by Bpifrance, announce the creation of an industrial company, AFYREN NEOXY.

AgroSavfe raises €35 million in Series C financing

Sofinnova Partners Announces the Sale of Breath Therapeutics to Zambon

AgroSavfe appoints Patrice Sellès as new Chief Executive Officer and further strengthens leadership team

Labiotech.eu - The Business of Biotech: What to Do When the S*#t Hits the Fan - Antoine Papiernik

Comet Bio Completes Equity Financing and Opens U.S. Headquarters in Chicagoland Area

ABIVAX Completes €12 Million Capital Raise Entirely Subscribed by Sofinnova Partners at Market Price

AblaCare Announces Series A Financing of €10 Million by Sofinnova Partners for Innovative Infertility Treatment and Appoints Jodie Fam as CEO

DMC Biotechnologies, Inc. Announces First Close of $10.3M Series A Financing Led by Sofinnova Partners

Comet Therapeutics Raises $28.5 Million Series A Financing to Support Development of Treatments Built Around Its Novel CoEnzyme A Platform

Sofinnova Partners’ DNA Script Raises $38.5 Million in Series B Financing

CinCor Pharma In-Licenses Aldosterone Synthase Inhibitor, CIN-107, and Closes $50 Million Series A Financing

Sofinnova leads 28-7 Therapeutics' $15M Series A extension

HOOKIPA Pharma Announces Pricing of Initial Public Offering

NodThera Highlights Significant Progress with Advancement of Lead Development Candidate and Key Additions to Board

SafeHeal obtains CE-mark for Colovac, its novel endoluminal bypass sheath

AFYREN and the SPI industrial projects fund, operated by Bpifrance, announce the creation of an industrial company, AFYREN NEOXY.